Related Experiment Video
Updated: Jan 24, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
New oncologic emergencies: What is there to know about inmunotherapy and its potential side effects?
Arantzazu Barquín-García1, Javier Molina-Cerrillo2, Pilar Garrido1
1Medical Oncology Department, Ramon y Cajal University Hospital, Ctra. Colmenar Km 9100 s/n, Madrid 28034, Spain.
Abstract:
Over the last decade anticancer treatment has experienced encouraging changes. One of the latest developments is immunotherapy, which is increasingly becoming a mainstay for the treatment of these malignancies. Unlike conventional chemotherapy, immunotherapy enhances anti-tumor immune response by blocking inhibitory immune checkpoints, and allowing our own immune system to fight against the tumor cells, arising as a new and innovative mechanism of action. Therefore, although well tolerated, these drugs have a unique side effect profile and are known to cause immune-related adverse events (irAEs). Adverse effects of immunotherapy are most commonly observed in the skin, gastrointestinal tract, liver, lung and endocrine systems. Less common toxicities may include neurological, haematological, cardiac, ocular or rheumatologic involvement. As far as we know, cancer patients are frequently seen in the Emergency Department due to treatment related toxicities, thus there is an increasing necessity to learn about this particular side effect profile given that they entail a different and unique management than that of classic chemotherapy drugs.
Related Concept Videos
Tumor Immunotherapy
Emerging Adulthood
Introduction Cardiac Emergencies
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Applications of GIS: Disaster Management and Emergency Response
Standard Electrode Potentials

